HFS
BCAX

Hughes Financial Services’s Bicara Therapeutics BCAX Stock Holding History

Hughes Financial Services’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30 Buy
+1
New +$22 ﹤0.01% 1710

Other funds holding BCAX

RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Hughes Financial Services's BCAX Position: Q2 2026 in Review

Hughes Financial Services opened a new position in Bicara Therapeutics (BCAX) in Q2 2026: 1 share worth $30. The stake represents ﹤0.01% of the portfolio and ranks #1710 among its holdings.

10 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Hughes Financial Services held 1 share of Bicara Therapeutics worth $30 as of Q2 2026.
  • Bicara Therapeutics was a new Hughes Financial Services position in Q2 2026.
  • Bicara Therapeutics made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1710 holding.
  • 10 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.